Relapsed/refractory thrombotic thrombocytopenic purpura treated with N-acetylcysteine: a case report

Scott Med J. 2018 Nov;63(4):122-124. doi: 10.1177/0036933018775240. Epub 2018 May 8.

Abstract

Thrombotic thrombocytopenic purpura is a rare condition that presents with microangiopathic haemolytic anaemia, thrombocytopaenia, fever, renal impairment and neurological symptoms. Plasma exchange is a lifesaving treatment for this condition. However, some cases may be non-responsive to plasma exchange, or loss of response may occur. Treatment options for refractory cases include high-dose corticosteroids, rituximab, vincristine, cyclophosphamide, splenectomy, bortezomib and N-acetylcysteine. We present a refractory case of thrombotic thrombocytopenic purpura responding to the last of these therapies.

Keywords: N-acetylcysteine; Thrombotic thrombocytopenic purpura; refractory; relapsed.

Publication types

  • Case Reports

MeSH terms

  • Acetylcysteine / therapeutic use*
  • Adult
  • Female
  • Humans
  • Purpura, Thrombotic Thrombocytopenic / drug therapy*
  • Recurrence

Substances

  • Acetylcysteine